alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 76, Number 52 (Thursday, March 17, 2011)]
[Notices]
[Page 14690]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-6163]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 18, 2010, and published in the Federal 
Register on December 3, 2010, (75 FR 75498), Agilent Technologies, 
25200 Commercentre Drive, Lake Forest, California 92630-8810, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471)........................  II
1-piperidinocyclohexanecarbonitrile (8603)..  II
Benzoylecgonine (9180)......................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances for use in diagnostic products.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Agilent Technologies to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Agilent Technologies to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed.

    Dated: March 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-6163 Filed 3-16-11; 8:45 am]
BILLING CODE 4410-09-P
EX-10.18



 Exhibit 10.18 
  





 
 February 18, 2016 

To: Sheri Brumm 

Re: Promotion to SVP, Chief Accounting Officer and Section 16 Officer 

Ultra Clean Holdings, Inc. (the “Company” or “UCT”) is pleased to offer you the regular, full time position of SVP, Chief
Accounting Officer (CAO). You will be appointed a Section 16 Officer of the UCT Company. 
 Base Salary. Your annual base rate
will be $265,000, payable bi-weekly in accordance with our regular payroll practices and in accordance with all applicable state and federal laws. 

Management Bonus. You will be eligible for the management bonus plan which includes an initial target payout of 40% of your base salary
on an annualized basis 
 Restricted Stock Units. You will receive a promotion grant of 15,000 restricted stock units of Ultra Clean
Holdings, Inc., with 1/3 of the award vesting upon each anniversary of the date of the grant, subject to the terms and conditions of our Amended and Restated Stock Incentive Plan. 

Severance Benefits. In the event your employment is terminated by the Company without Cause or by you for Good Reason, then, subject to
your compliance with the terms and conditions of the Company’s Severance Benefits for Executive Officers policy, as amended through the date hereof (the “Severance Policy”), you will be entitled to the severance benefits set forth in
the Severance Policy. 
 Sincerely, 
  





 
 Jim Scholhamer, 

CEO 
  
 



 
 Casey Eichler, 

President & CFO 
 UCT 

26462 Corporate Ave., Hayward, CA 94545 
 Tel:
(510) 576-4400    Fax: (510) 576-4401    www.uct.com
### §714a. Location of offices

The Corporation may establish offices in such place or places as it may deem necessary or desirable in the conduct of its business.

(June 29, 1948, ch. 704, §3, 62 Stat. 1070.)

#### **Executive Documents**

#### Exceptions From Transfer of Functions

For exception of functions of corporations of Department of Agriculture from transfer of functions to Secretary of Agriculture by Reorg. Plan No. 2 of 1953, see Exceptions From Transfer of Functions note set out under section 712a of this title.
#### § 385.1306 Intervention by State commissions (Rule 1306).

Any interested State commission may intervene in any proceeding before the Federal Energy Regulatory Commission, as provided in Rule 214.
Exhibit


Exhibit (10)LL


 

January 14, 2016
 
Tina Tyler
    
Re:    Short-Term Incentive Plan 


Dear Tina:


This letter establishes the terms on which you may be eligible for a bonus under Target’s 2015 Short-Term Incentive Plan, given that you were employed for over 11 months of fiscal 2015.  


Target’s Short-Term Incentive Plan brochure states that you must be employed at the time of bonus payment, currently scheduled for March 2016, to be eligible for bonus compensation.  As part of your overall separation package from Target, which includes the Income Continuance Agreement and Non-Competition, Non-Solicitation and Confidentiality Agreement, you will be eligible for a full fiscal 2015 short-term incentive payout opportunity under Target’s Short-Term Incentive Plan.  


This bonus opportunity will be based on the bonus program terms in effect on the date your employment ended, except that you will be eligible for a bonus calculated as if you were employed through the payment date.  It will be calculated using Target’s actual financial performance for fiscal 2015, as certified by the Human Resources and Compensation Committee, and the median of the last three personal review scores you received.  Any such bonus will be paid in accordance with Target’s customary practice.  


Please let me know if you have any questions about this matter.




Sincerely,




/s/ Jodee Kozlak


Jodee Kozlak 
Executive Vice President & Chief Human Resources Officer 
Target Corporation
Editorial Note on Part 0
Editorial Note: Nomenclature changes to part 0 appear at 73 FR 73 FR 54947, Sept. 24, 2008.

§ 0.53 Immigrant and Employee Rights Section. ( a ) The Immigrant and Employee Rights Section shall be headed by a Special Counsel for Immigration-Related Unfair Employment Practices (“Special Counsel”). The Special Counsel shall be appointed by the President for a term of four years, by and with the advice and consent of the Senate, pursuant to section 274B of the Immigration and Nationality Act (INA), 8 U.S.C. 1324b. The Immigrant and Employee Rights Section shall be part of the Civil Rights Division of the Department of Justice, and the Special Counsel shall report directly to the Assistant Attorney General, Civil Rights Division.
( b ) In carrying out the Special Counsel's responsibilities under section 274B of the INA, the Special Counsel is authorized to: ( 1 ) Investigate charges of unfair immigration-related employment practices filed with the Immigrant and Employee Rights Section and, when appropriate, file complaints with respect to those practices before specially designated administrative law judges within the Office of the Chief Administrative Hearing Officer, Executive Office for Immigration Review, U.S. Department of Justice;
( 2 ) Intervene in proceedings involving complaints of unfair immigration-related employment practices that are brought directly before such administrative law judges by parties other than the Special Counsel;
( 3 ) Conduct, on the Special Counsel's own initiative, investigations of unfair immigration-related employment practices and, where appropriate, file complaints with respect to those practices before such administrative law judges;
( 4 ) Conduct, handle, and supervise litigation in U.S. District Courts for judicial enforcement of subpoenas or orders of administrative law judges regarding unfair immigration-related employment practices;
( 5 ) Initiate, conduct, and oversee activities relating to the dissemination of information to employers, employees, and the general public concerning unfair immigration-related employment practices;
( 6 ) Establish such regional offices as may be necessary, in accordance with regulations of the Attorney General;
( 7 ) Perform such other functions as the Assistant Attorney General, Civil Rights Division may direct; and
( 8 ) Delegate to any subordinate any of the authority, functions, or duties vested in the Special Counsel.
[AG Order 3791-2016, 81 FR 91789, Dec. 19, 2016]
**EXHIBIT 32.1**
**CERTIFICATION**
     Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of2002 (18 U.S.C. § 1350, as adopted), J. William Freytag, the Chief Executive Officer of Myogen,Inc. (the “Company”), and Joseph L. Turner, the Chief Financial Officer of the Company, each herebycertifies that, to the best of his knowledge:
     **1. **The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2005, towhich this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies withthe requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, asamended; and
     **2. **The information contained in the Periodic Report fairly presents, in all materialrespects, the financial condition of the Company at the end of the period covered by the PeriodicReport and results of operations of the Company for the periods covered by the Periodic Report.   Dated: May 10, 2005     /s/ J. William Freytag /s/ Joseph L. Turner   J. William Freytag Joseph L. Turner*Chief Executive Officer* *Chief Financial Officer**(Principal Executive Officer)* *(Principal Financial Officer)*
     A signed original of this written statement required by Section 906 has been provided toMyogen, Inc. and will be retained by Myogen, Inc. and furnished to the Securities and ExchangeCommission (“SEC”) or its staff upon request. This certification “accompanies” the Form 10-Q towhich it relates, is not deemed filed with the SEC and is not to be incorporated by reference intoany filing of the Company under the Securities Act of 1933, as amended, or the Securities ExchangeAct of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective ofany general incorporation language contained in such filing.
### SUBCHAPTER VI—MISCELLANEOUS

#### **Editorial Notes**

#### Codification

This subchapter was enacted as part of the Magnuson-Stevens Fishery Conservation and Management Reauthorization Act of 2006, and not as part of the Magnuson-Stevens Fishery Conservation and Management Act which comprises this chapter.
10.11 

11/8/04 

 Page 1 

Quitting Tobacco: Enjoying Coffee and Tea ... Without Smoking 

What To Expect 

• Expect that your morning coffee will not taste the same without a cigarette. 

• Expect to feel a strong urge to reach for a cigarette while drinking coffee or tea. 

Did You Know? 

• Many smokers are used to smoking when drinking coffee or tea during or after meals, 

during coffee/tea breaks, in the office, or in restaurants. 

• You do not have to give up coffee or tea to quit smoking. 

What To Do 

• If you used to smoke while drinking coffee or tea, tell people you have quit, so they 

won’t offer you a cigarette. 

• Between sips of coffee or tea, take deep breaths to inhale the aroma. Breathe deeply and 

slowly, while you count to five, breathe out slowly, counting to five again. 

• Try switching to decaffeinated coffee for a while, particularly if quitting has made you 

irritable or nervous. 

• Try nibbling on healthy foods to keep your hands busy while you drink coffee or tea. 

• As you drink your coffee, get out a scratch pad, doodle, or make plans for the day. 

• If the urge to smoke is very strong, drink your coffee or tea faster than usual and then 

change activities or rooms. 

Nicotine and Your Body and Mind 

• Many studies have reported that smoking may make you feel happier and more alert. 

Smokers may associate these good feelings with drinking coffee or tea. When you quit 

smoking, you may feel saddened by the loss of these good feelings, and drinking coffee 

or tea without smoking may make you feel even sadder. Try not to feel sad; think of 

what you’ve gained by quitting. 

Related Notes 

• Nicotine cravings may be reduced by using nicotine replacement products, which deliver 

small, steady doses of nicotine into the body. Nicotine replacement patches, gum, 

lozenges, nasal spray, and inhaler appear to be equally effective. Buproprion pills (which 

don’t contain nicotine) also help relieve withdrawal symptoms. 
10.11 

11/8/04 

 Page 2 

How To Get Help 

• If you or someone you know wants help with giving up tobacco, please call the National 

Cancer Institute’s Smoking Quitline toll-free at 1–877–44U–QUIT (1–877–448–7848). 

The information specialists on the Quitline can provide suggestions and support to help 

smokers break the habit. 

• The Federal Government’s Smokefree.gov Web site (http://www.smokefree.gov) allows 

you to choose the help that best fits your needs. You can get immediate assistance: 

o View an online step-by-step cessation guide. 

o Find state quitline telephone numbers. 

o Instant message an expert through NCI’s LiveHelp service. 

o Download, print, or order publications about quitting smoking. 

# # # 

This fact sheet was reviewed on 11/8/04 

This fact sheet was adapted from material developed by the Tobacco Education and Prevention Program 

of the Arizona Department of Health Services and the Arizona Smokers’ Helpline of the University of 

Arizona.
-       - Superintendent of Documents
      - 2023-09-01T21:21:20-0400
      - Government Publishing Office, Washington, DC 20401
      - Government Publishing Office
      - Government Publishing Office attests that this document has not been altered since it was disseminated by Government Publishing Office
Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Cedar Grove Marketing, Inc.,
on Form  10-QSB  for the  period  ending  December  31,  2002 as filed  with the
Securities  and  Exchange  Commission  on the date  hereof (the  "Report"),  the
undersigned, B. Stephen Bailey, Chief Executive Officer and Principal Accounting
Officer of the Company,  certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to ss. 906 of the  Sarbanes-Oxley  Act of 2002,  that to the best of my
knowledge and belief:

         1. The Report fully complies with the requirements of section 13 (a) or
15 (d) of the Securities Exchange Act of 1934; and

         2. The  information  contained in the Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.


Date: April 19, 2004

/s/ B. Stephen Bailey
B. Stephen Bailey
President
(Principal Executive & Accounting Officer)


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.
### §713a–14. Repealed. Pub. L. 113–79, title I, §1423(a), Feb. 7, 2014, 128 Stat. 695

Section, Pub. L. 99–198, title I, §153, Dec. 23, 1985, 99 Stat. 1377; Pub. L. 100–418, title IV, §4308, Aug. 23, 1988, 102 Stat. 1399; Pub. L. 100–435, title I, §106, Sept. 19, 1988, 102 Stat. 1651; Pub. L. 101–624, title I, §114, Nov. 28, 1990, 104 Stat. 3380; Pub. L. 103–465, title IV, §411(b), Dec. 8, 1994, 108 Stat. 4963; Pub. L. 104–127, title I, §148, Apr. 4, 1996, 110 Stat. 920; Pub. L. 107–171, title I, §1503(a), May 13, 2002, 116 Stat. 207; Pub. L. 110–234, title I, §1503, May 22, 2008, 122 Stat. 992; Pub. L. 110–246, §4(a), title I, §1503, June 18, 2008, 122 Stat. 1664, 1721, related to the dairy export incentive program.
EXHIBIT 32.a
 
 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In connection with the Annual Report of Boston Capital Tax Credit Fund IV L.P. (the “Fund”) on Form 10-K for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Manning, Principal Executive Officer of the general partner of the general partner of the Fund’s general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:
 
 (1)
The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and
 
 (2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Fund.
 
 Date:July 13, 2011
/s/ John P. ManningJohn P. ManningPrincipal Executive Officer
 
 A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
<PAGE>   1
        Congress Talcott Corporation (Western)
        5670 Wilshire Boulevard  Suite 1750
        Los Angeles California  90036
        213 954-5300

March 4, 1997



Mr. Fred Findley
Jalate, Ltd.                                    [CONGRESS TALCOTT LOGO]
1675 S. Alameda
Los Angeles, CA  90015

        Re:     Jalate, Ltd. ("Client");
                Congress Talcott Corporation (Western) ("Congress")

Dear Fred,

Reference is hereby made to that certain Discount Factoring Agreement dated
August 17, 1987 between Client and Congress as amended from time to time (the
"Factoring Agreement").  In connection with the Factoring Agreement, Congress
and Client entered into a letter agreement, dated May 17, 1995 (the "May 17th
agreement").  This letter agreement supersedes the May 17th agreement as
follows:

        1)      Purchase of any fixed or capital assets not to exceed
                $750,000.00 in the aggregate during any one year term of the
                Factoring Agreement.  Jalate, Ltd. shall not, without the prior
                written consent of Congress Talcott Corporation (Western) make
                any capital expenditures in any fiscal year in excess of
                750,000.00.

Except as specifically provided herein, all terms and conditions of the
agreement remain in full force and effect, without waiver or modification.  If
you agree to the terms and conditions contained in this letter agreement,
please indicate your agreement by executing this letter agreement where
indicated below and returning this letter agreement to the undersigned.

                                 Very truly yours,

                                 Congress Talcott Corporation (Western)

                                 /s/ MATTHEW J. PICCOLO

                                 Matthew J. Piccolo
                                 Vice President

Agreed and Accepted this 7th day March, 1997

Jalate, Ltd.

By:_______________________________

Title:____________________________

              [CONGRESS TALCOTT LOGO    NEW YORK  *  LOS ANGELES]
**Exhibit
        13.2**
  **CERTIFICATION
        PURSUANT TO 18 U.S.C. SECTION 1350,**
 **AS
        ADOPTED PURSUANT TO**
 **SECTION
        906 OF THE U.S. SARBANES-OXLEY ACT OF 2002**
  In
        connection with the Annual Report of TELEFÓNICA DE ARGENTINA S.A. (the
“Company”) on Form 20-F for the fiscal year ended December 31, 2006, as filed
        with the U.S. Securities and Exchange Commission on the date hereof (the
        “Report”), I, Juan Ignacio López Basavilbaso, Chief Financial Officer, certify,
        pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of
        the
        U.S. Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
  (i)  the
        Report
        fully complies with the requirements of section 13(a) or 15(d) of the U.S.
        Securities Exchange Act of 1934; and
  (ii)  the
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
  Date:
        April 4, 2007


By:
              /s/
                  Juan Ignacio López BasavilbasoName:
              Juan Ignacio
                López
                BasavilbasoTitle:
              Chief Financial
                Officer
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           6,443
<SECURITIES>                                         0
<RECEIVABLES>                                   31,686
<ALLOWANCES>                                     1,297
<INVENTORY>                                          0
<CURRENT-ASSETS>                                66,190
<PP&E>                                          44,454
<DEPRECIATION>                                   7,865
<TOTAL-ASSETS>                                 735,340
<CURRENT-LIABILITIES>                           62,791
<BONDS>                                        125,185
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             5
<OTHER-SE>                                     187,845
<TOTAL-LIABILITY-AND-EQUITY>                   735,340
<SALES>                                        144,519
<TOTAL-REVENUES>                               122,522
<CGS>                                                0
<TOTAL-COSTS>                                  113,131
<OTHER-EXPENSES>                                   131
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              34,411
<INCOME-PRETAX>                               (25,151)
<INCOME-TAX>                                     7,252
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (17,899)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>